Table 2.

Associations of Participant Characteristics with Log Transformed Myocardial SUVmean

	Univariate Models		Extended MV Model		Reduced MV Model
	β	p-value	β	p-value	β	p-value
Age, per year	−0.0004	0.92
Male vs female	−0.11	0.39
Non-Hispanic white	referent		referent
Non-Hispanic black	0.34	0.029	0.20	0.24
Hispanic	0.17	0.14	0.064	0.63
Other race	−0.093	0.74	−0.12	0.67
Ever smoking vs. never	−0.023	0.82
Hypertension, yes v. no	0.0030	0.98
BMI, per kg/m2	0.018	0.042	0.014	0.10	0.015	0.068
Diabetes, yes v. no	−0.17	0.27
Total cholesterol, per mg/dL	−0.0017	0.22	−0.0015	0.29
LDL, per mg/dL	−0.0010	0.55
HDL, per mg/dL	−0.0016	0.56
log Triglycerides, per mg/dL	−0.11	0.36
RA duration (square root), per year	0.010	0.74
RF or anti-CCP, yes v. no	0.011	0.93
DAS28-CRP>3.2 units	0.22	0.039
CDAI >10 units	0.31	0.006	0.25	0.047	0.28	0.012
log CRP, per mg/L	0.0047	0.91
log IL-6, per pg/mL	0.015	0.74
log BNP, per pg/mL	0.0009	0.75
AM stiffness (square root), per min	0.0052	0.71
HAQ, per unit	0.11	0.099	−0.019	0.79
Methotrexate, yes v. no	0.13	0.22	0.12	0.27
No biologic	referent		referent		referent
TNF inhibitors	−0.080	0.48	−0.029	0.80	−0.023	0.83
Non-TNF biologics	−0.38	0.043	−0.36	0.047	−0.38	0.033
Current prednisone, yes v. no	0.14	0.21
Current NSAID, yes v. no	0.067	0.52
CAC score zero	referent		referent		referent
CAC score <100	0.018	0.90	0.041	0.77	0.037	0.78
CAC score ≥100	−0.22	0.10	−0.25	0.073	−0.21	0.10
Adjusted R2			0.105	0.025	0.102	0.006

Legend: Beta coefficients represent the average change in the Log Transformed Myocardial SUVmean per 1-unit higher value of the independent continuous variable of interest or for those with versus those without the independent dichotomous variable of interest. RA: rheumatoid arthritis, RF: rheumatoid factor, CCP: cyclic citrullinated protein antibody, DAS: disease activity score, CDAI: clinical disease activity index HAQ: health assessment questionnaire, AM: morning, CRP: C-reactive protein, IL-6: interleukin 6, CAC: coronary artery calcium